Study Of Pharmaceutical Preparation Of Osteocalcium-5 For Primary Osteoprosis After Menopause
- VernacularTitle:Цэвэршилтийн Дараах Анхдагч Ясны Сийрэгжилттэй Эмэгтэйчүүдэд Остеокальци-5 Бэлдмэлийн Үзүүлэх Нөлөөгуламжлалт Анагаах Ухааны Биеийн Өвөрчлөлттэй Харьцуулан Судласан Нь
- Author:
Byambadalai D
1
;
Мunkhzol M
1
;
Seesregdorj S
1
Author Information
- Publication Type:Journal Article
- Keywords: Journal article
- From: Journal of Oriental Medicine 2015;9(2):56-60
- CountryMongolia
- Language:Mongolian
- Abstract: Determining effect of pharmaceutical preparation of Osteocalcium-5 for 50-65years old patients who diagnosed as primary osteoprosis after menopause. All 120 volunteers were divided randomly into control and clinical experiemental group also private specialty test was taken from each group as well. Control group (n60) had oral medication Citratcalcium D, clinical experiement group had oral Osteocalcium-5. After medication result of mineral density of osteoprosis , fracture risk and result of private specialty were compared. Result: 65.8% of patients who diagnosed as primary osteoprosis after menopause are concept of Badgan private specialty. After 2 months of oral medication in each group SOS measurement enhanced by 3-4%, fracture risk decreased by 39.6%. Conclution: In Traditional medical, concept of Badgan private specialty more tendency for osteoprosis. Osteocalcium-5 improves osteon of compact bone patiets with osteoprosis after menopause and decreased risk of fracture. Also result of pharmaceutical preparation of Osteocalcium -5 does not depend on private specialty but patients who are active lifestyle and stomach fire is proper had possitive effect.
